Drug use issues and actions. Study sheds light on lifetime treatment costs of protease inhibitor-containing antiretroviral regimens.
- Published in:
- 2000
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2000 AND VI 35 AND IP 2
Results: 24
1
2
Drug use issues and actions. CHF pathway increases ACE inhibitor prescribing.
- Published in:
- 2000
- Publication type:
- Journal Article
3
Drug use issues and actions. Chemotherapy protocol improves safe use of agents at community hospital.
- Published in:
- 2000
- Publication type:
- Journal Article
4
Pharmacoeconomic model to evaluate new influenza treatments: study design.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
5
Nonsteroidal anti-inflammatory drugs: review of factors guiding formulary selection.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
6
Eletriptan: serotonin 5-HT 1B/1D receptor agonist for the acute treatment of migraine.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
7
Drug watch.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 196
- Publication type:
- Article
8
Health care community under pressure to reduce medication errors.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 191
- By:
- Publication type:
- Article
9
Bacterial resistance to TMP-SMX up markedly, particularly among HIV-infected patients.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 190
- Publication type:
- Article
10
Rofecoxib induces significantly fewer GI events than nonselective NSAIDs.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 190
- Publication type:
- Article
11
Study sheds light on lifetime treatment costs of protease inhibitor-containing antiretroviral...
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 189
- Publication type:
- Article
12
CHF pathway increases ACE inhibitor prescribing.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 185
- Publication type:
- Article
13
Chemotherapy protocol improves safe use of agents at community hospital.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 185
- Publication type:
- Article
14
Pharmacoeconomic model to evaluate new influenza treatments.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 169
- By:
- Publication type:
- Article
15
Nonsteroidal anti-inflammatory drugs: Review of factors guiding formularly selection.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 142
- By:
- Publication type:
- Article
16
Serotonin 5-HT 1B/1D receptor agonist for the acute treatment of migraine.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 129
- By:
- Publication type:
- Article
17
Study supports first-line combination endocrine therapy for premenopausal breast cancer.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 128
- Publication type:
- Article
18
Cost-utility analysis finds IFN-beta-1b unjustified for secondary progressive MS.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 126
- Publication type:
- Article
19
Pegylated interferon promises first effective treatment for hepatitis C and related cirrhosis.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 125
- Publication type:
- Article
20
Gains in use of drug utilization controls fail to offset bigger gains in HMO drug spending.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 120
- Publication type:
- Article
21
Study boosts role of NNRTI-based triple therapy as initial HIV treatment.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 120
- Publication type:
- Article
22
FDA drug approvals.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 110
- Publication type:
- Article
23
Best of the class.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 108
- Publication type:
- Article
24
NME, biologic approvals.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 106
- Publication type:
- Article